William Guyer, Chief Development Officer at CORCEPT THERAPEUTICS INC (CORT), sold 1,356 shares at $114.51 ($155K) on 2025-04-01, disclosed to the SEC on 2025-04-02.
Scheduled sale ($155k) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.51 | 678 | $78K | 50.0% |
| 2 | $114.51 | 678 | $78K | 50.0% |
| Total | $114.51 avg | 1,356 | $155K | 100% |
| Filing → |
| CORT | SELL | 2026-06-04 | $1.4M | — | Filing → |
| CORT | SELL | 2026-05-07 | $1.0M | — | Filing → |
| CORT | SELL | 2026-04-08 | $819K | — | Filing → |